<DOC>
	<DOCNO>NCT01307566</DOCNO>
	<brief_summary>The main purpose study measure evolution hemoglobin A1c level treatment CPAP cohort type 2 diabetes mellitus patient poor glycemic control associate moderate severe obstructive sleep apnea .</brief_summary>
	<brief_title>Evolution With CPAP Treatment Cohort Type 2 Diabetic Patients With Apnea-hypopnea Syndrome</brief_title>
	<detailed_description>Subjects poorly control type 2 diabetes high cardiovascular risk group high prevalence moderate severe sleep apnea expect . Studies base interstitial glycemic measurement demonstrate reduction glucose level treat sleep apnea CPAP . Nevertheless , effectiveness CPAP improve glycemic control question study fail demonstrate reduction hemoglobin A1c ( HbA1C ) level time . Most study limitation short follow-up suboptimal fulfillment CPAP treatment . We hypothesize treat moderate severe sleep apnea CPAP improve glycemic control ( measure HbA1C ) 14 week good compliers improvement sustain one year . We aim test hypothesis consecutive type 2 diabetes patient stable treatment HbA1c ≥7 % routine outpatient visit Diabetes , Nutrition Endocrinology Unit . After provide informed consent , patient screen sleep apnea nocturnal oximetry follow diagnostic respiratory polygraphy . Those patient obstructive sleep apnea apnea-hypopnea index ≥20 invite enter study . After 3-month observation period without intervention rule potential influence enter study HbA1C level , patient treat CPAP . HbA1C level measure baseline , 14 week , thereafter every 14 week complete one year treatment . Other endocrine , metabolic cardiovascular risk variable determine baseline 14 week intervention .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<criteria>Inclusion criterion : Type 2 diabetes stable treatment last three month HbA1C ≥ 7 % Obstructive Sleep Apnea apneahypopnea index ≥20 Acceptance therapeutic trial CPAP Exclusion criterion : Race : non caucasic Blood level hemoglobin &lt; 10 woman &lt; 11 men iron defitiency hemoglobinopathy Glomerular filtration rate &lt; 30 Habitual sleeping time &lt; 6 hour per night Nocturnal work , shift work unsual sleeping schedule Primary severe insomnia secondary restless legs syndrome Major non stable psychiatric disorder Treatment corticosteroids Chronic respiratory disorder may require corticosteroid cause respiratory insufficiency FEV1/FVC &lt; 0.7 FEV1 &lt; 50 spirometry Predominant nocturnal hypoventilation pattern Cardiac failure Alcohol abuse Active CPAP treatment Previous surgery sleep apnea Severe nasal obstruction Illiteracy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>